Although CRP is endorsed by the GLIM criteria as a valuable supportive proxy measure (1) due to its sensitivity in reflecting variations in the inflammatory state (37), examining the burden of diseases associated with inflammation (e.g., heart failure), with or without additional inflammatory markers (e.g., interleukins), as part of the etiological criteria, could provide further insights. The gene discussed is CRP; the disease is heart failure.